At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Epidemiology Study to Assess Plasmodium Falciparum Parasite Prevalence and Malaria Control Measures in Catchment Areas of Two Interventional Studies Pre- and Post RTS,S/AS01E Introduction (EPI MAL-002 and EPI-MAL-003) to Assess, in Field Conditions, Vaccine Benefit: Risk in Children in Sub Saharan Africa
In Brief
A Phase 4 clinical trial evaluating Assessment of body temperature and Blood sampling for Malaria and Malaria Vaccines. Completed, enrolled 54,115 participants across 12 sites in 6 countries.
Detailed Summary
This epidemiology study was conducted in parallel with the EPI-MAL-002 (NCT02374450) and EPI-MAL-003 (NCT03855995) studies, enrolling participants from the same health and demographic surveillance system (HDSS) (or equivalent system) populations. The co-primary objectives were to produce longitudinal estimates of parasite prevalence in humans and to record the usage of malaria control measures in areas where the EPI-MAL-002 and EPI-MAL-003 studies were conducted.
Study Details
Timeline
Interventions
Axillary body temperature of all participants recorded by a digital thermometer at the time of survey.
Capillary blood samples collected by finger/heel prick for determination of parasite prevalence at the time of survey.